Clinical trial
Caspofungin Study for Fungal Infections in Adults in Critical Care Settings
NCT00095316 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Terminated
Key facts
| NCT number | NCT00095316 |
|---|---|
| Title | Caspofungin Study for Fungal Infections in Adults in Critical Care Settings |
| Official title | A Randomized, Double-Masked Trial of Caspofungin Versus Placebo as Prophylaxis of Invasive Candidiasis in High-Risk Adults in the Critical Care Setting |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Candidiasis |
| Intervention type | Drug, Other |
| Interventions | Caspofungin, Placebo |
| Enrollment | 1,200 |
| Start date | Oct 1, 2004 |
| Completion | Sep 1, 2006 |
| First posted | Nov 3, 2004 |
| Last update posted | Dec 5, 2014 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: